Literature DB >> 32988582

Multi-domain unfolding of the Fab fragment of a humanized anti-cocaine mAb characterized by non-reducing SDS-PAGE.

Terence L Kirley1, Andrew B Norman2.   

Abstract

Monoclonal antibodies and their fragments are widely used for research and therapy. Fab fragments are useful since they retain antigen binding specificity, but being smaller proteins, are better able to penetrate biological compartments and tumors, and do not induce Fc-dependent immunological system activation. Our laboratory developed an anti-cocaine mAb (named h2E2) for the treatment of cocaine use disorders, which is currently in advanced pre-clinical development. We are also interested in the Fab fragment of this mAb for potential therapy of acute cocaine overdose. Previously, we showed that this mAb and its F(ab')2 and Fab fragments undergo discrete domain unfolding, as detected by non-reducing SDS-PAGE, and that ligand-induced protein thermal stabilization can be quantitated utilizing differential scanning fluorimetry in the absence of SDS. Here, we demonstrate that multiple Fab protein gel bands observed using non-reducing SDS-PAGE in the presence and absence of cocaine and its metabolites can be explained and interpreted based on the differential stabilization of two unfolding domains in the Fab fragment. The variable domain is stabilized by ligands against SDS unfolding, while the constant domain is not. This data and its interpretation are also supported by differential scanning fluorimetry data for the Fab fragment in SDS. It is likely that these non-reducing SDS-PAGE results and the gel band domain unfolding model will be applicable to other small molecule binding antibodies. Thus, non-reducing SDS-PAGE is a widely available and simple method for assessing domain stability and multi-step unfolding of Fab fragments.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody domain unfolding; Cocaine binding; Electrophoretic migration; Fab fragment; Monoclonal antibody; Non-reducing SDS-PAGE

Year:  2020        PMID: 32988582      PMCID: PMC7655625          DOI: 10.1016/j.bbrc.2020.09.051

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate.

Authors:  Hanna N Wetzel; Rose P Webster; Fatima O Saeed; Terence L Kirley; William J Ball; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2017-04-23       Impact factor: 3.575

Review 2.  Medications development: successes and challenges.

Authors:  Frank Vocci; Walter Ling
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Structural analysis of free and liganded forms of the Fab fragment of a high-affinity anti-cocaine antibody, h2E2.

Authors:  Kemin Tan; Min Zhou; Angela J Ahrendt; Norma E C Duke; Nassif Tabaja; William J Ball; Terence L Kirley; Andrew B Norman; Andrzej Joachimiak; Marianne Schiffer; Rosemarie Wilton; P Raj Pokkuluri
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-11-05       Impact factor: 1.056

5.  The effects of a humanized recombinant anti-cocaine monoclonal antibody on the disposition of cocaethylene in mice.

Authors:  Hanna N Wetzel; Michael R Tabet; William J Ball; Andrew B Norman
Journal:  Int Immunopharmacol       Date:  2014-12       Impact factor: 4.932

6.  A novel differential scanning fluorimetry analysis of a humanized anti-cocaine mAb and its ligand binding characteristics.

Authors:  Terence L Kirley; Andrew B Norman; Hanna N Wetzel
Journal:  J Immunol Methods       Date:  2019-10-18       Impact factor: 2.303

7.  Simultaneous High-Throughput Conformational and Colloidal Stability Screening Using a Fluorescent Molecular Rotor Dye, 4-(4-(Dimethylamino)styryl)-N-Methylpyridinium Iodide (DASPMI).

Authors:  Jensen J H Wong; Sara K Wright; Irene Ghozalli; Rajni Mehra; Kenji Furuya; Derrick S Katayama
Journal:  J Biomol Screen       Date:  2016-05-02

8.  A recombinant humanized anti-cocaine monoclonal antibody inhibits the distribution of cocaine to the brain in rats.

Authors:  Andrew B Norman; Felicia C T Gooden; Michael R Tabet; William J Ball
Journal:  Drug Metab Dispos       Date:  2014-04-14       Impact factor: 3.922

9.  Unfolding of IgG domains detected by non-reducing SDS-PAGE.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2018-06-23       Impact factor: 3.575

10.  Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE.

Authors:  Terence L Kirley; Kenneth D Greis; Andrew B Norman
Journal:  Biochem Biophys Rep       Date:  2018-10-31
View more
  4 in total

1.  Tyrosine nitration of a humanized anti-cocaine mAb differentially affects ligand binding of cocaine and its metabolites.

Authors:  Terence L Kirley; Kenneth D Greis; Andrew B Norman
Journal:  Biochem Biophys Rep       Date:  2022-05-14

2.  Ligand binding to a humanized anti-cocaine mAb measured by dye absorption spectroscopy.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Biochem Biophys Res Commun       Date:  2020-12-18       Impact factor: 3.575

3.  Isothermal titration calorimetry determination of thermodynamics of binding of cocaine and its metabolites to humanized h2E2 anti-cocaine mAb.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  Biochem Biophys Rep       Date:  2022-09-24

4.  Cocaine binding to the Fab fragment of a humanized anti-cocaine mAb quantitated by dye absorption and fluorescence spectroscopy.

Authors:  Terence L Kirley; Andrew B Norman
Journal:  J Immunol Methods       Date:  2021-07-21       Impact factor: 2.287

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.